SCHEMBL20698249

SCHEMBL20698249

c1ccc2c(c1)nc1sc3c(-c4ccc5c6ccccc6c6cc7c8ccccc8c8ccccc8c8ccccc8c7cc6c6ccccc6c5c4)cccc3n12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.41
KDM4E B2RXH2 4/20 0.41
SMN1; SMN2 Q16637 6/20 0.39
HPGD P15428 6/20 0.39
TP53 P04637 5/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
LMNA P02545 3/20 0.39
FLT3 P36888 3/20 0.38
BMX P51813 2/20 0.38
POLB P06746 4/20 0.36
MAPT P10636 3/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPK1 P28482 2/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 3/20 0.34
PTP4A3 O75365 1/20 0.34
PTP4A1 Q93096 1/20 0.34
MEN1 O00255 2/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20735395 0.95 KDM4E (0.39) HSD17B10KDM4ESMN1; SMN2HPGDTP53
SCHEMBL20735399 0.86 KDM4E (0.34) HSD17B10KDM4ESMN1; SMN2HPGDTP53
SCHEMBL16441925 0.86 FLT3 (0.38) HSD17B10KDM4ESMN1; SMN2HPGDTP53
SCHEMBL18701339 0.86 HSD17B10 (0.43) HSD17B10KDM4ESMN1; SMN2HPGDTP53
SCHEMBL16441891 0.85 CHEK2 (0.39) HSD17B10KDM4ESMN1; SMN2HPGDTP53
SCHEMBL16441929 0.84 KDM4E (0.39) HSD17B10KDM4ESMN1; SMN2HPGDTP53
SCHEMBL16441888 0.83 KDM4E (0.43) HSD17B10KDM4ESMN1; SMN2HPGDTP53
SCHEMBL16441889 0.83 KDM4E (0.46) HSD17B10KDM4ESMN1; SMN2HPGDTP53
SCHEMBL16441890 0.83 KDM4E (0.48) HSD17B10KDM4ESMN1; SMN2HPGDTP53
SCHEMBL20698250 0.82 HSD17B10 (0.39) HSD17B10KDM4ESMN1; SMN2HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11322691-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-05-03 US disclosed
US-20190036031-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11322691-B2 Organic electroluminescent materials and devices CTCF, AZI2, CACNA2D2 HSD17B10 3814/4885KDM4E 617/4885SMN1; SMN2 4264/4885
US-20190036031-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES CTCF, CACNA2D2, PPA1 HSD17B10 4007/4885KDM4E 1083/4885SMN1; SMN2 4472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.